Lv11
40 积分 2026-07-17 加入
Haematopoietic cell transplantation for relapsed or refractory classical Hodgkin lymphoma: a retrospective, registry-based cohort study of 19 498 patients from the EBMT Lymphoma Working Group
1个月前
已完结
Evolution of CAR T-cell immunotherapy in terms of patenting activity
1个月前
已完结
Donor- and patient-derived interleukin 6 knockdown CD19-targeted chimeric antigen receptor T cells exhibit similar efficacy and safety in treating relapsed B-cell acute lymphoblastic leukemia patients after allogeneic hematopoietic stem cell transplantation
1个月前
已完结
Sequential CD19/CD22 CAR-T cell therapy following ASCT shows improved efficacy versus CAR-T alone in relapsed/refractory large B-cell lymphoma
1个月前
已完结
Cancer burden and control in China: landscape, trends and challenges
1个月前
已完结
皖公网安备34019202002308
